AUTL - Autolus Therapeutics plc
1.48
0.060 4.054%
Share volume: 1,538,589
Last Updated: 04-28-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.20%
PREVIOUS CLOSE
CHG
CHG%
$1.42
0.06
0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-17-2024 | 08-08-2024 | 11-12-2024 | 03-20-2025 | 05-08-2025 | 08-12-2025 | 11-12-2025 | 03-27-2026 | |
| Assets | |||||||||
| Total Assets | 901.436 M | 853.620 M | 827.490 M | 782.725 M | 746.338 M | 720.981 M | 661.947 M | 589.068 M | |
| Current Assets | 804.298 M | 758.600 M | 718.114 M | 660.929 M | 615.773 M | 574.250 M | 514.577 M | 435.915 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 4.138 M | 14.647 M | 23.943 M | 27.723 M | 33.209 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 360.643 M | 420.776 M | 330.454 M | 281.289 M | 196.578 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 758.529 M | 705.939 M | 657.067 M | 227.380 M | 95.799 M | 123.825 M | 86.124 M | 104.132 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 33.414 M | 32.860 M | 44.258 M | 49.553 M | 57.970 M | 66.467 M | 66.851 M | 63.563 M | |
| Other Assets | 63.724 M | 62.160 M | 65.118 M | 72.243 M | 72.595 M | 80.264 M | 80.519 M | 89.590 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 901.436 M | 853.620 M | 827.490 M | 782.725 M | 746.338 M | 720.981 M | 661.947 M | 589.068 M | |
| Total liabilities | 319.406 M | 325.776 M | 350.525 M | 355.400 M | 375.230 M | 374.517 M | 396.495 M | 410.939 M | |
| Total current liabilities | 43.985 M | 40.904 M | 52.474 M | 60.743 M | 66.615 M | 68.151 M | 83.071 M | 73.440 M | |
| Accounts Payable | 1.399 M | 1.098 M | 1.418 M | 1.969 M | 4.457 M | 5.408 M | 10.967 M | 3.083 M | |
| Other liabilities | 46.927 M | 46.209 M | 49.108 M | 50.057 M | 55.178 M | 306.366 M | 313.424 M | 337.499 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 46.927 M | 46.209 M | 49.108 M | 50.057 M | 55.178 M | 306.366 M | 313.424 M | 337.499 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 582.030 M | 527.844 M | 476.965 M | 427.325 M | 371.108 M | 346.464 M | 265.452 M | 178.129 M | |
| Common stock | 1.542 B | 1.545 B | 1.549 B | 1.556 B | 1.559 B | 1.563 B | 1.567 B | 1.570 B | |
| Retained earnings | -931.252 M | -989.524 M | -1.072 B | -1.099 B | -1.169 B | -1.217 B | -1.296 B | -1.387 B |